Ad
related to: will clindamycin treat sepsis disease infection in children
Search results
Results From The WOW.Com Content Network
Neonatal sepsis is a type of neonatal infection and ... clindamycin is often added. ... strains of infectious disease. [22] Current methods of treatment for EOS are ...
Meningitis is an infection that causes the thin layers of the meninges that surround the brain and spinal cord to become inflamed, explains Dr. Rodrigo Hasbun, an infectious diseases professor at ...
Group B streptococcal infection, also known as Group B streptococcal disease or just Group B strep infection, is the infectious disease caused by the bacterium Streptococcus agalactiae. Streptococcus agalactiae is the most common human pathogen belonging to group B of the Lancefield classification of streptococci —hence the name of group B ...
Clindamycin is a lincosamide antibiotic medication used for the treatment of a number of bacterial infections, including osteomyelitis (bone) or joint infections, pelvic inflammatory disease, strep throat, pneumonia, acute otitis media (middle ear infections), and endocarditis. [5]
For children with MRSA-infected bone or joints, treatment is individualized and long-term. Neonates can develop neonatal pustulosis as a result of topical infection with MRSA. [4] Clindamycin is not approved for the treatment of MRSA infection, but it is still used in children for soft-tissue infections. [4]
However, these classifications are based on laboratory behavior. The development of antibiotics has had a profound effect on the health of people for many years. Also, both people and animals have used antibiotics to treat infections and diseases. In practice, both treat bacterial infections. [1]
The WHO Model List of Essential Medicines for Children (aka Essential Medicines List for Children [1] or EMLc [1]), published by the World Health Organization (WHO), contains the medications considered to be most effective and safe in children up to twelve years of age to meet the most important needs in a health system.
People with a compromised immune system, such as those living with HIV, are also at higher risk of pneumococcal disease. [5] In HIV patients with access to treatment, the risk of invasive pneumoccal disease is 0.2–1% per year and has a fatality rate of 8%. [5] There is an association between pneumococcal pneumonia and influenza. [6]